{
  "id": 706112,
  "title": "Earnings call transcript: STAAR Surgical tops revenue views in Q2 2026",
  "url": "https://urgent.news/2026/08/12/earnings-call-transcript-staar-surgical-tops-revenue-views-in-q2-2026",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-12T22:31:44.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-staar-surgical-tops-revenue-views-in-q2-2026-93CH-4856405"
  },
  "original_language": "en",
  "account": null,
  "summary": "STAAR Surgical reported strong Q2 2026 revenue growth of $93.5 million, surpassing analysts' estimates, while earnings per share fell short at $0.16, below the expected $0.22. The company's APAC sales grew by 189% year-over-year, while the Americas increased by 12%, and EMEA decreased by 1%, though it still showed a 12% improvement excluding the Middle East. Despite the revenue miss, STAAR Surgical returned to profitability, with net income of $8.1 million, or $0.16 per share, compared to a loss of $16.8 million in the same quarter last year. The stock initially rose 1.88% in regular trading before falling 2.05% after hours, trading at $24.89, slightly below its 52-week high. Analysts forecast full-year 2026 EPS of $0.72, up from a trailing twelve months loss of $0.42 per share.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Earnings call transcript: Mister Spex lifts profit in H1 2026 as sales fall",
        "url": "https://urgent.news/2026/08/13/earnings-call-transcript-mister-spex-lifts-profit-in-h1-2026-as-sales",
        "published": "2026-08-13T08:07:59.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}